Hexahydrocyclopentyl[f]findazole sulfonamides and derivates thereof as selective glucocorticoid receptor modulators

Details for Australian Patent Application No. 2009220458 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors McMaster, Danielle M.; Dankulich, William P.; Meissner, Robert S.; Mitchell, Helen J.; Kaufman, Mildred L.

Agent Spruson & Ferguson

Pub. Number AU-A-2009220458

PCT Pub. Number WO2009/111214

Priority 61/068,370 06.03.08 US

Filing date 24 February 2009

Wipo publication date 11 September 2009

International Classifications

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111214 Priority application(s): WO2009/111214

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220462-CCR5 antagonists as prophylactics for preventing HIV infection and methods of inhibiting transmission of same

2009220444-Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-IV inhibitor